CYTH

Cyclo Therapeutics, Inc.

1.30 USD
-0.05 (-3.70%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Cyclo Therapeutics, Inc. stock is down -11.56% since 30 days ago. The next earnings date is Aug 12, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 31.03% of the previous 28 May’s closed higher than April. 100% of analysts rate it a buy.

About Cyclo Therapeutics, Inc.

Cyclo Therapeutics, Inc. was incorporated in 1990 and is based in Gainesville, Florida. Its lead drug candidate is Trappsol Cyclo, an orphan drug, which is Phase III clinical trials for the treatment of Niemann-Pick Type C disease. In addition, it sells cyclodextrins and related products to pharmaceutical, nutritional, and other industries.